Home›Companies›Healthcare›Motif Neurotech

Motif Neurotech, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 24, 2024·Suggest an edit

About Motif Neurotech

Motif Neurotech is a private company based in Houston, Texas, incorporated in 2022 in Delaware. It has reported $15,324,201 raised in one offering on Form D since January 2024. Its chief executive is Jacob Robinson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 12, 2024Jan 24, 2024$15,324,201of $21.5M target28$547KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Motif Neurotech's Form D filed Jan 24, 2024.

Anthony Arnold
Anthony Arnold
Director
Also a president & CEO, director at Sensydia and a chief executive officer and director at SetPoint Medical.
JR
Jacob Robinson
Chief Executive Officer and director
TS
Thomas Shehab
Director
Also a managing partner and director at Endogenex and a director at SonarMD and Virtual Incision.
AK
Amy Kruse
Director
Also a prime movers lab and director at Cognixion and a director at Gilgamesh Pharma and Morphoceuticals.

Sources

  1. SECMotif Neurotech, Inc. filing history